David Hall, M.D.
Research Awards Nationwide Recipient (2017-2018)
University of Florida
Increasing the Number of Suitable Donor Lungs for Transplantation
Currently, only 22 percent of lungs from multi-organ donors are used for transplantation; the majority of potential donor lungs are rejected due to poor function. A novel technique called ex vivo lung perfusion (EVLP) has been shown to improve marginal donor lungs to the level of standard-criteria lungs. Using deceased donor pig lungs, we will study a medication that blocks endothelin-1 (ET-1), which constricts blood vessels in the lungs. Previous studies have found ET-1 blockers reduce donor lung injury. If found safe and effective in these preclinical models, the ultimate goal will be a clinical trial that blocks ET-1 to improve and rehabilitate human lungs prior to transplantation, allowing potential expansion of the donor pool.
Sign up for the latest lung health news delivered right to your inbox.
Join more than 500,000 people who receive research updates, inspiring stories, health information and more.